Commentary: Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: a multi-omics analysis with experimental verification

Jihao Xue(Affiliated Hospital of Southwest Medical University), Yanling Li(Shandong University of Traditional Chinese Medicine), Ming Wang(Wenzhou Medical University)
Frontiers in Immunology
December 18, 2024
Cited by 0


Related Papers